PCR: Pharma LCA Consortium

The Pharmaceutical Environment Group (PEG) is a collaborative initiative between leading healthcare companies working together to improve environmental sustainability. Projects include the Pharmaceutical Life-Cycle Assessment Consortium, which develops Product Category Rules (PCRs) to set robust guidelines for estimating and reporting product life cycle environmental impacts.

Whether it’s addressing climate change impact and reaching Net Zero emissions; embracing a shift to circularity; measuring and reducing the impact of products throughout their lifecycle; or understanding and measuring our interaction with the natural world, PEG participating companies recognize their responsibility to minimize and reduce their environmental footprint. They also know that often these issues cannot be addressed in isolation – they need shared ambitious thinking and meaningful collaboration.

Learn more on peghub.org
The project
How Quantis can help

The high complexity and diversity of pharmaceuticals and their productions makes standardization critical.

Collaborating for new standards

The consortium collaborated with Pharmaceutical Environment Group (PEG) and National Health Service England to support the development of PAS 2090 — a sector-wide standard for pharmaceutical life cycle assessment (LCA).

The consortium and NHS England are working with the British Standards Institution (BSI) to reach consensus among the sector’s stakeholder groups: healthcare systems, providers and professionals, representative bodies, academics and patients.

Members: Astra Zeneca, GSK, Novo Nordisk, Roche, Pfizer, Johnson & Johnson, Sanofi, Takeda, Merck KGaA, Merck MSD, Novartis

How Quantis can help

For two decades, our dynamic and visionary team has partnered with organizations across the globe to transform their industries and shape a new, planetary economy that aligns business with nature.

We guide industries on the transition from business as usual to business at its best.

Let’s talk

  • Scoping the project

    Quantis helped research the sector to define the best path to create the consortium.

  • Setting methodology + strategy

    Quantis assisted with footprinting methodology and development of data.

  • Run independent testing

    Quantis helped define pilot products and integrate feedback from external testers.

  • Validating the LCA tool

    Quants prepared training material to prepare tool development for the next phase.